Current stock page

Catalysts

INBX Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

INBXInhibrx Biosciences Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

BearishEdge 6/10
$83.30−$4.45 (−5.07%)

Latest quote

  • Momentum
    50
  • Value
    —
  • Quality
    28
  • Risk resilience
    40
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 40/100

Momentum 50/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 13.98%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 50/100AIQ Edge 6/10 Above Peers
Beat rate
25%
2 of 8 reported periods
Average surprise
+1.8%
Across covered historical reports
Latest result
-0.4%
Nov 13, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 13, 2026—-$2.45-$2.46-0.4%$1.9M$2M
Aug 13, 2026—-$2.28-$2.34-2.6%——
May 14, 2026—-$2.37-$2.15+9.3%——
Mar 19, 2026—-$2.08-$2.11-1.4%$1.11M—
Nov 14, 2025—-$2.08-$2.28-9.6%——
Aug 13, 2025—-$2.92-$1.85+36.6%—$1.3M
May 14, 2025—-$2.55-$2.80-9.8%——
Mar 17, 2025—-$2.88-$3.09-7.3%—$100K

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
3
Buy
1
Hold
12-month analyst target
$245.00
+194.12% versus current price
Based on 4 analyst observations. Targets are estimates, not predictions.
Low target
$245.00
+194.12% vs latest price
Average target
$245.00
+194.12% vs latest price
High target
$245.00
+194.12% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score50

Where event reaction would show up first.

AIQ score40/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
4
Average target
$245.00
Target upside
194.12%
Target range
$245.00 - $245.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
1
Negative
1
insidermonkey.com · Sep 24, 2026

Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall?

Inhibrx Biosciences, Inc. (NASDAQ:INBX) delivered the kind of clinical update that would normally be expected to get investors’ attention.

gurufocus.com · Sep 24, 2026

INBX Insider Jon Kayyem Buys 5,000 Shares Amid High Price-to-Sales Valuation

On September 23, 2026, Inhibrx Biosciences Inc (NASDAQ: INBX) disclosed that its director, Jon Kayyem, purchased 5,000 shares of common stock for $500,000. This

gurufocus.com · Sep 9, 2026

Inhibrx Biosciences (INBX) Stock Rises 7% Amid Insider Buying and Mixed Valuation Signals

On September 09, 2026, Inhibrx Biosciences Inc (NASDAQ: INBX) experienced a notable stock price increase of over 7%, fueled by significant insider purchases fro

seekingalpha.com · Sep 9, 2026

Inhibrx: Market's Lukewarm Response To Yesterday's HNSCC Data Hard To Fathom (NASDAQ:INBX)

Inhibrx (INBX) updates: ozekibart & INBRX-106 show strong rare cancer and immuno-oncology data; FDA BLA due Apr 2027.

Open full news and sentiment

INBX Catalysts FAQ

What are the next catalysts for INBX stock?

INBX's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move INBX stock?

Upcoming events that could move INBX include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could INBX's next earnings report affect the stock?

INBX's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive INBX stock higher?

INBX could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt INBX stock?

INBX could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.